31DEC05: Kymanox Sends Happy New Year Wishes to Clients, Partners and Friends!
08DEC05: Kymanox Holiday Happy Hour
Clients and friends of Kymanox in the RTP, NC area are welcome to attend a Holiday Happy Hour from 5-7 pm near RDU airport on 14DEC05.
02NOV05: iBIO's Midwest Meeting in Chicago
Stephen M. Perry, PMP attended this 6th annual meeting in preparation for BIO 2006, which is scheduled to take place in Chicago for the first time this coming April. Some of the topics covered at the iBIO Midwest Meeting included: research tools, patents and licenses, public policy and market trends. G. Steven Burrill, CEO of Burrill & Company, was the main speaker and sponsor for the event.
23SEP05: BioProcess International 2005 World Conference and Exhibition in Boston, MA
Kymanox President, Stephen M. Perry, PMP, attended this IBC Life Sciences conference from September 19-22, 2005. The following biopharmaceutical production topics were addressed: (1) production & economics , (2) scale-up from bench to clinic, (3) cell culture & upstream processing and (4) recovery & purification (agenda-at-a-glance / full-brochure). Several people enjoyed a clipper ship cruise hosted by Irvine Scientific, including representatives from Amgen (.jpg) and Diosynth Biotechnology (.jpg). Mr. Perry looks forward to seeing everyone again next year!
03AUG05: Kymanox Organizes as a Limited Liability Company (LLC)
Kymanox today organized as an LLC in the State of Illinois. LLC's are similar to corporations as they establish a separate legal identity from their owners and managers. The new legal name is "Kymanox, LLC." However, "Kymanox" will still be used as the primary company identifier on documents, marketing materials, etc.
05MAY05: Version 2.0 Web Site Unveiled
Kymanox has reprogrammed its web site using Macromedia's Dreamweaver MX 2004. The known incompatibility issues with Microsoft's FrontPage server extensions were the primary driving force behind this change; Mozilla and Mac users can now access the site. Please browse for new and old content in the new layout. The old web site can be accessed at http://www.kymanox.com/v1
27APR05: Kymanox's Stephen M. Perry completes PMI's PMP Certification
With a passing score on PMI's Project Management Professional (PMP) exam, Stephen M. Perry is now a certified PMP. Professional project management encompasses 9 key knowledge areas within 5 process groups, plus ethical and code-of-conduct standards. Mr. Perry took the initial 7-day certification course from the International Institute for Learning (IIL) and successfully completed the application and exam process on the first attempt.
21APR05: Kymanox is Introduced to Comprehensive Compliance Solutions, Inc. (CCS)
Kymanox was introduced to Comprehensive Compliance Solutions, Inc. (CCS), a consulting company based near the D.C. Metro area. Founders Ms. Betty Jones and Ms. Sandra Whetstone have extensive experience at the FDA and are well-suited to provide strategic regulatory guidance in the following categories: drugs, biologics, medical devices, foods and animal feed & drugs. In addition to assisting companies with FDA audits and solving compliance issues, CCS is also focused on prevention and risk assessment to help guide quality, regulatory and business decision making.
11APR05: President of ASI Meets with Kymanox
Kymanox met with long-time acquaintance and ASI (Automated Systems, Inc.) President Laszlo Kulcsar. Stephen Perry worked closely with ASI while at Abbott Laboratories. ASI was the key factor in successfully meeting the requirements and deadlines of several large validation projects in the R10 Recovery Pilot Plant. ASI has a skilled and experienced workforce numbering over 50 and provides variety of compliance, systems development and consulting services.
07APR05: Kymanox Meets AsahiKASEI Representatives
Kymanox was able to meet key business, marketing and technical representatives from AsahiKASEI (Planova Division), which has headquarters in Japan. AsahiKASEI is the manufacturer of Planova® filters. These hollow-fiber filter cartridges may be used for virus removal during protein purification of cell culture products. AsahiKASEI utilizes a specialized Gold Particle Test (GPT) for post-use integrity testing. Combined with a simple leak test, GPT provides a comprehensive and validation-capable system for virus removal, which is essential for process validation and, ultimately, ensuring product safety. The company is currently developing a fully-automated integrity testing unit, called the AGTPS, to further enhance testing throughput, ease-of-use and regulatory compliance.
07APR05: TechniKrom's Skid and Column Technologies Are Reintroduced to a Biotechnology Manufacturer
TechniKrom, Inc. utilizes key technologies, like Adaptive PAT® and Dynamic Axial Compression (DAC), that are paving the way for improved manufacturing control and efficiency. Adaptive PAT® is well-aligned with the FDA's publicized initiative for implementing Process Analytical Technology (PAT). TechniKrom is an experienced, full-service equipment manufacture and Kymanox is pleased to recommend TechniKrom to manufacturers that can benefit from their specialized products and services.
24MAR05: Kymanox Meets President of Regis Technologies
Today Kymanox met with Louis Glunz, IV, President of Regis Technologies, Inc. A tour was provided of the cGMP facility qualified to manufacture small-molecule active pharmaceutical ingredients (APIs) and specialty intermediates. Mr. Glunz is a University of Notre Dame alum and hails from the prominent and successful Glunz family. Based on Mr. Glunz's idea, Kymanox and Regis Technologies are interested in organizing a Fall 2005 meeting with Chicago-area Notre Dame alums that are involved in pharmaceutical-related business, science and engineering; if you are interested, please send email to firstname.lastname@example.org.
24FEB05: Kymanox Visits Startup in Bloomington, IN
Cook Pharmica is currently building a new biotech contract manufacturing organization (CMO) in the heart of the Midwest. This is a welcome sign of an expanding biotech industry that historically has been concentrated on US coasts and locations overseas. Cook Pharmica is making smart-use of a vacant television assembly plant to serve as an outer shell for its brand new facility. Kymanox was pleased to meet President Jerry C. Arthur who is parlaying his success with Cook Pharmaceutical Solutions which was sold to Baxter in 2001 for $219 million. Mr. Arthur has a related feature article in BioProcess International (Feb05 / Vol 3 / Supplement 1) titled, "A Case Study in Parenteral Filling: Modular Construction Meets the Need for Speed."
01FEB05: Kymanox Finalizes First Proposal
A major milestone was achieved today as Kymanox finalized its first contract.
30JAN05: Kymanox News Update (RE: Web site)
Kymanox goes live with its first web site, Version 1.0. Frequent updates are scheduled in the next several weeks based on anticipated feedback. Visitors are encouraged to provide feedback (i.e., comments, questions or suggestions) by sending an email to email@example.com.